Can at Scale Drug Provision Improve the Health of the Targeted in Sub-Saharan Africa?

Working Paper: NBER ID: w23403

Authors: Adrienne M. Lucas; Nicholas L. Wilson

Abstract: The single largest item in the United States foreign aid health budget is antiretroviral therapy (ART) for the treatment of HIV/AIDS. Many supply- and demand-side factors in sub-Saharan Africa could cause smaller than expected epidemiological effects of this at scale drug provision. We provide what appears to be the first quasi-experimental evidence on the effect of at scale drug provision in a poor country, using the phased roll-out of ART in Zambia, a setting where approximately 1 in 6 adults are HIV positive. Combining anthropometric data from national household surveys and a spatially-based triple difference specification, we find that local ART introduction increased the weight of high HIV likelihood adult women. This finding from a clinically difficult setting suggest that the generalized challenges of scalability of ART for adult health in sub-Saharan Africa are surmountable.

Keywords: antiretroviral therapy; HIV/AIDS; public health; Zambia; foreign aid

JEL Codes: H51; I12; I15; I18; O12; O15


Causal Claims Network Graph

Edges that are evidenced by causal inference methods are in orange, and the rest are in light blue.


Causal Claims

CauseEffect
local ART introduction (Z11)increase in the weight of high HIV likelihood women (I14)
local ART introduction (Z11)improved health outcomes (I14)
increase in the weight of high HIV likelihood women (I14)improved health outcomes (I14)
local ART introduction (Z11)no significant change in height (O41)

Back to index